These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23831873)

  • 21. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
    Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psychotic disorders related with chronic use of mephedrone. Case report].
    Urban M; Rudecki T; Wróblewski D; Rabe-Jabłońska J
    Psychiatr Pol; 2011; 45(3):431-7. PubMed ID: 22232972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAM-2201 (analytically confirmed) intoxication after "Synthacaine" consumption.
    Lonati D; Buscaglia E; Papa P; Valli A; Coccini T; Giampreti A; Petrolini VM; Vecchio S; Serpelloni G; Locatelli CA
    Ann Emerg Med; 2014 Dec; 64(6):629-32. PubMed ID: 24530110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How much can synthetic cannabinoid damage the heart? A case of cardiogenic shock following resistant ventricular fibrillation after synthetic cannabinoid use.
    Yamanoglu A; Celebi Yamanoglu NG; Evran T; Sogut O
    J Clin Ultrasound; 2018 Nov; 46(9):605-609. PubMed ID: 29479764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
    Tanibuchi Y; Matsumoto T; Kobayashi O; Wada K
    Seishin Shinkeigaku Zasshi; 2013; 115(5):463-76. PubMed ID: 23855225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reports of adverse health effects related to synthetic cannabinoid use in New York State.
    Papadopoulos EA; Cummings KR; Marraffa JM; Aldous KM; Li L; Ahmad N
    Am J Addict; 2017 Dec; 26(8):772-775. PubMed ID: 29105968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Suicidal attempts among young people hospitalized in the department of psychiatry of the Medical Academy in Lublin in 1990-1997].
    Kucharska-Pietura K; Loza B; Szymona K; Makara-Studzińska M
    Psychiatr Pol; 2000; 34(3):423-33. PubMed ID: 11055181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations.
    Harlow BL; Vitonis AF; Sparen P; Cnattingius S; Joffe H; Hultman CM
    Arch Gen Psychiatry; 2007 Jan; 64(1):42-8. PubMed ID: 17199053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life.
    Werbeloff N; Drukker M; Dohrenwend BP; Levav I; Yoffe R; van Os J; Davidson M; Weiser M
    Arch Gen Psychiatry; 2012 May; 69(5):467-75. PubMed ID: 22213772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic cannabinoid use: recognition and management.
    Castellanos D; Thornton G
    J Psychiatr Pract; 2012 Mar; 18(2):86-93. PubMed ID: 22418399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of the 2013 Psychoactive Substances Act and mental health harms from synthetic cannabinoids.
    Glue P; Courts J; MacDonald M; Gale C; Mason E
    N Z Med J; 2015 May; 128(1414):15-8. PubMed ID: 26117386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adolescent admissions to adult psychiatric units: patterns and implications for service provision.
    Park C; McDermott B; Loy J; Dean P
    Australas Psychiatry; 2011 Aug; 19(4):345-9. PubMed ID: 21879868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric admission in a general hospital. Patients profile and patterns of service utilization over a decade.
    AbuMadini MS; Rahim SI
    Saudi Med J; 2002 Jan; 23(1):44-50. PubMed ID: 11938363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients.
    Clark BC; Georgekutty J; Berul CI
    J Pediatr; 2015 Sep; 167(3):757-61.e1. PubMed ID: 26165442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organic and synthetic cannabinoid use in adolescents.
    Bhatty S; Wu W
    Pediatr Ann; 2013 Jan; 42(1):31-5. PubMed ID: 23316832
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthetic cannabinoid use in psychiatric patients and relationship to hospitalisation: A retrospective electronic case register study.
    Hobbs M; Patel R; Morrison PD; Kalk N; Stone JM
    J Psychopharmacol; 2020 Jun; 34(6):648-653. PubMed ID: 32108548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risky recreation: synthetic cannabinoids have dangerous effects.
    McGuinness TM; Newell D
    J Psychosoc Nurs Ment Health Serv; 2012 Aug; 50(8):16-8. PubMed ID: 22801822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of physical exercise in psychiatry: a therapeutic approach?].
    Tordeurs D; Janne P; Appart A; Zdanowicz N; Reynaert C
    Encephale; 2011 Oct; 37(5):345-52. PubMed ID: 22032277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
    Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
    Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.